Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Malherbe, Stephanus T."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 61
Tytuł:
Field evaluation of a point-of-care triage test for active tuberculosis (TriageTB).
Autorzy:
Richardson TR; Stellenbosch University, Cape Town, South Africa. .
Smith B; Stellenbosch University, Cape Town, South Africa.
Malherbe ST; Stellenbosch University, Cape Town, South Africa.
Shaw JA; Stellenbosch University, Cape Town, South Africa.
Noor F; Stellenbosch University, Cape Town, South Africa.
MacDonald C; Stellenbosch University, Cape Town, South Africa.
van der Spuy GD; Stellenbosch University, Cape Town, South Africa.
Stanley K; Stellenbosch University, Cape Town, South Africa.
Carstens A; Stellenbosch University, Cape Town, South Africa.
Fisher TL; Stellenbosch University, Cape Town, South Africa.
van Rensburg I; Stellenbosch University, Cape Town, South Africa.
Flinn M; Stellenbosch University, Cape Town, South Africa.
Snyders C; Stellenbosch University, Cape Town, South Africa.
Johnson I; Stellenbosch University, Cape Town, South Africa.
Fransman B; Stellenbosch University, Cape Town, South Africa.
Dockrell H; London School of Hygiene and Tropical Medicine, London, UK.
Thwaites G; University of Oxford, Oxford, UK.
Thuong NTT; University of Oxford, Oxford, UK.
Schacht C; LINQ Management, Berlin, Germany.
Mayanja-Kizza H; Makerere University, Kampala, Uganda.
Nsereko M; Makerere University, Kampala, Uganda.
Tjon Kon Fat EM; Leiden University Medical Centre, Leiden, The Netherlands.
Corstjens PLAM; Leiden University Medical Centre, Leiden, The Netherlands.
Geluk A; Leiden University Medical Centre, Leiden, The Netherlands.
Ruhwald M; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
Penn-Nicholson A; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
Chegou NN; Stellenbosch University, Cape Town, South Africa.
Sutherland J; London School of Hygiene and Tropical Medicine, Banjul, The Gambia.
Walzl G; Stellenbosch University, Cape Town, South Africa.
Pokaż więcej
Corporate Authors:
TrENDx consortium
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Jul 03; Vol. 23 (1), pp. 447. Date of Electronic Publication: 2023 Jul 03.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Tuberculosis*/diagnosis
Mycobacterium tuberculosis*
Humans ; Point-of-Care Systems ; Triage ; Point-of-Care Testing ; Sensitivity and Specificity ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Optimising the yield from bronchoalveolar lavage on human participants in infectious disease immunology research.
Autorzy:
Shaw JA; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa. .; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa. .; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa. .
Meiring M; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.; South African Tuberculosis Bioinformatics Initiative, Stellenbosch University, Cape Town, South Africa.
Allies D; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
Cruywagen L; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
Fisher TL; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
Kasavan K; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
Roos K; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
Botha SM; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
MacDonald C; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
Hiemstra AM; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
Simon D; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
van Rensburg I; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
Flinn M; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
Shabangu A; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
Kuivaniemi H; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
Tromp G; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.; South African Tuberculosis Bioinformatics Initiative, Stellenbosch University, Cape Town, South Africa.; Centre for Bioinformatics and Computational Biology, Stellenbosch University, Stellenbosch, South Africa.
Malherbe ST; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
Walzl G; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
du Plessis N; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Biomedical Research Institute, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa.
Pokaż więcej
Corporate Authors:
Stellenbosch University Immunology Research Group Bronchoalveolar Lavage Study Consortium (SU IRG BAL Study Consortium)
Źródło:
Scientific reports [Sci Rep] 2023 May 31; Vol. 13 (1), pp. 8859. Date of Electronic Publication: 2023 May 31.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
HIV Infections*
COVID-19*
Tuberculosis*
Humans ; Aged ; Bronchoalveolar Lavage Fluid ; SARS-CoV-2 ; Bronchoalveolar Lavage
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes.
Autorzy:
Sivakumaran D; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, University of Bergen, Bergen, Norway.
Jenum S; Department of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Vaz M; Department of Physiology, St. John's Medical College and Division of Health and Humanities, St. John's Research Institute, Koramangala, Bangalore, India.
Selvam S; Division of Infectious Diseases, St. John's Research Institute, Koramangala, Bangalore, India.
Ottenhoff THM; Department of Infectious Diseases Group, Immunology and Immunogenetics of Bacterial Infectious Disease, Leiden University Medical Center, Leiden, the Netherlands.
Haks MC; Department of Infectious Diseases Group, Immunology and Immunogenetics of Bacterial Infectious Disease, Leiden University Medical Center, Leiden, the Netherlands.
Malherbe ST; DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Doherty TM; GlaxoSmithKline Vaccines, Wavre, Belgium.
Ritz C; Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark. .
Grewal HMS; Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, University of Bergen, Bergen, Norway.
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2020 Jul 09; Vol. 3 (1), pp. 359. Date of Electronic Publication: 2020 Jul 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Markers*
Transcriptome*
Antitubercular Agents/*therapeutic use
Mycobacterium tuberculosis/*isolation & purification
Sputum/*microbiology
Tuberculosis/*blood
Adolescent ; Adult ; Aged ; Female ; Follow-Up Studies ; Humans ; India/epidemiology ; Male ; Middle Aged ; Predictive Value of Tests ; Prospective Studies ; ROC Curve ; Treatment Outcome ; Tuberculosis/drug therapy ; Tuberculosis/epidemiology ; Tuberculosis/microbiology ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response.
Autorzy:
Penn-Nicholson A; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Mbandi SK; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Thompson E; Center for Infectious Disease Research, Seattle, WA, USA.
Mendelsohn SC; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Suliman S; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.; Brigham and Women's Hospital, Division of Rheumatology, Immunity and Inflammation, Harvard Medical School, Boston, USA.
Chegou NN; DST-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Malherbe ST; DST-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Darboe F; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Erasmus M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Hanekom WA; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Bilek N; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Fisher M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Kaufmann SHE; Max Planck Institute for Infection Biology, Berlin, Germany.; Hagler Institute for Advanced Study at Texas A&M University, College Station, TX, USA.
Winter J; Catalysis Foundation for Health, San Ramon, CA, USA.
Murphy M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Wood R; Desmond Tutu HIV Centre, and Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
Morrow C; Desmond Tutu HIV Centre, and Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
Van Rhijn I; Brigham and Women's Hospital, Division of Rheumatology, Immunity and Inflammation, Harvard Medical School, Boston, USA.
Moody B; Brigham and Women's Hospital, Division of Rheumatology, Immunity and Inflammation, Harvard Medical School, Boston, USA.
Murray M; Department of Global Health and Social Medicine, and Division of Global Health Equity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Andrade BB; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil.
Sterling TR; Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, USA.
Sutherland J; Vaccines and Immunity, Medical Research Council Unit, Fajara, The Gambia.
Naidoo K; Centre for the AIDS Programme of Research in Africa, Durban, South Africa.; South African Medical Research Council-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.
Padayatchi N; Centre for the AIDS Programme of Research in Africa, Durban, South Africa.; South African Medical Research Council-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.
Walzl G; DST-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Zak D; Center for Infectious Disease Research, Seattle, WA, USA.
Scriba TJ; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa. .
Pokaż więcej
Corporate Authors:
Adolescent Cohort Study team
GC6-74 Consortium
SATVI Clinical and Laboratory Team
ScreenTB Consortium
AE-TBC Consortium
RePORT Brazil Team
Peruvian Household Contacts Cohort Team
CAPRISA IMPRESS team
Źródło:
Scientific reports [Sci Rep] 2020 May 25; Vol. 10 (1), pp. 8629. Date of Electronic Publication: 2020 May 25.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Real-Time Polymerase Chain Reaction/*methods
Tuberculosis/*diagnosis
Adolescent ; Area Under Curve ; Biomarkers/metabolism ; Cohort Studies ; Female ; HIV Infections/complications ; HIV Infections/pathology ; Humans ; Lung/diagnostic imaging ; Lung/innervation ; Lung/pathology ; Male ; Mycobacterium tuberculosis/genetics ; Mycobacterium tuberculosis/isolation & purification ; Point-of-Care Systems ; Positron-Emission Tomography ; Prognosis ; RNA, Bacterial/metabolism ; ROC Curve ; Sensitivity and Specificity ; Tuberculosis/complications ; Tuberculosis/microbiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Accuracy of diabetes screening methods used for people with tuberculosis, Indonesia, Peru, Romania, South Africa.
Autorzy:
Grint D; Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, England.
Alisjhabana B; Infectious Disease Research Centre, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
Ugarte-Gil C; Facultad de Medicina Alberto Hurtado, Universidad Peruana Cayetano Heredia, Lima, Peru.
Riza AL; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, Netherlands.
Walzl G; Division of Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa.
Pearson F; Population Health Research Institute, St George's University of London, Cranmer Terrace, London SW17 0RE, England.
Ruslami R; Infectious Disease Research Centre, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
Moore DAJ; Laboratorio de Investigación y Desarrollo, Universidad Peruana Cayetano Heredia, San Martin de Porres, Peru.
Ioana M; Human Genomics Laboratory, Universitatea de Medicina si Farmacie din Craiova, Craiova, Romania.
McAllister S; Centre for International Health, University of Otago, Dunedin, New Zealand.
Ronacher K; Mater Medical Research, Translational Research Institute, University of Queensland, Brisbane, Australia.
Koeseomadinata RC; Infectious Disease Research Centre, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
Kerry-Barnard SR; Population Health Research Institute, St George's University of London, Cranmer Terrace, London SW17 0RE, England.
Coronel J; Laboratorio de Investigación y Desarrollo, Universidad Peruana Cayetano Heredia, San Martin de Porres, Peru.
Malherbe ST; Division of Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa.
Dockrell HM; Department of Immunology and Infection, London School of Hygiene & Tropical Medicine, London, England.
Hill PC; Centre for International Health, University of Otago, Dunedin, New Zealand.
Van Crevel R; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, Netherlands.
Critchley JA; Population Health Research Institute, St George's University of London, Cranmer Terrace, London SW17 0RE, England.
Pokaż więcej
Corporate Authors:
TANDEM consortium
Źródło:
Bulletin of the World Health Organization [Bull World Health Organ] 2018 Nov 01; Vol. 96 (11), pp. 738-749. Date of Electronic Publication: 2018 Aug 27.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Diabetes Mellitus, Type 2/*diagnosis
Diabetes Mellitus, Type 2/*epidemiology
Mass Screening/*methods
Tuberculosis/*epidemiology
Adult ; Age Factors ; Blood Glucose ; Body Weights and Measures ; Female ; Glycated Hemoglobin ; Humans ; Indonesia ; Male ; Middle Aged ; Peru ; Point-of-Care Testing ; Prospective Studies ; ROC Curve ; Risk Factors ; Romania ; Sex Factors ; South Africa
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa
Autorzy:
Hiemstra, Andriёtte M.Aff1, Aff2, Aff3, Aff4, IDs12879022073498_cor1
MacDonald, Candice E.Aff1, Aff2, Aff3, Aff4
van Rensburg, Ilana C.Aff1, Aff2, Aff3, Aff4
Stanley, KimAff1, Aff2, Aff3, Aff4
Maasdorp, EliznaAff2, Aff3, Aff4, Aff5, Aff6
Mc Anda, ShirleyAff1, Aff2, Aff3, Aff4
Tönsing, SusanneAff1, Aff2, Aff3, Aff4
Shaw, Jane AlexandraAff1, Aff2, Aff3, Aff4
Tromp, GerardAff2, Aff3, Aff4, Aff5, Aff6
van der Spuy, Gian D.Aff2, Aff3, Aff4, Aff5, Aff6
Urdahl, Kevin B.Aff7, Aff8
Lewinsohn, David M.
Kuivaniemi, HelenaAff2, Aff3, Aff4
Du Plessis, NelitaAff2, Aff3, Aff4
Malherbe, Stephanus T.Aff1, Aff2, Aff3, Aff4
Walzl, GerhardAff1, Aff2, Aff3, Aff4, Aff5
Pokaż więcej
Źródło:
BMC Infectious Diseases. 22(1)
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response
Autorzy:
Malherbe, Stephanus T.Aff1, Aff2
Chen, Ray Y.
Dupont, PatrickAff5, Aff6
Kant, Ilse
Kriel, MagdalenaAff1, Aff2
Loxton, André G.Aff1, Aff2
Smith, BronwynAff1, Aff2
Beltran, Caroline G. G.Aff1, Aff2
van Zyl, SusanAff1, Aff2
McAnda, ShirelyAff1, Aff2
Abrahams, CharmaineAff1, Aff2
Maasdorp, EliznaAff1, Aff2, Aff7
Doruyter, AlexAff8, Aff11
Via, Laura E.Aff4, Aff8
Barry, III, Clifton E.Aff1, Aff2, Aff4, Aff8
Alland, David
Richards, Stephanie Griffith-
Ellman, Annare
Peppard, Thomas
Belisle, John
Tromp, GerardAff1, Aff2, Aff7
Ronacher, KatharinaAff1, Aff2, Aff13
Warwick, James M.
Winter, Jill
Walzl, GerhardAff1, Aff2
Pokaż więcej
Źródło:
EJNMMI Research. 10(1)
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A semi-automatic technique to quantify complex tuberculous lung lesions on F-fluorodeoxyglucose positron emission tomography/computerised tomography images
Autorzy:
Malherbe, Stephanus T.Aff1, Aff2
Dupont, PatrickAff3, Aff4
Kant, Ilse
Ahlers, PetriAff1, Aff2
Kriel, MagdalenaAff1, Aff2
Loxton, André G.Aff1, Aff2
Chen, Ray Y.
Via, Laura E.Aff5, Aff6
Thienemann, FriedrichAff6, Aff7
Wilkinson, Robert J.Aff6, Aff7, Aff8, Aff9
Barry, III, Clifton E.Aff1, Aff2, Aff5, Aff6
Griffith-Richards, Stephanie
Ellman, Annare
Ronacher, KatharinaAff1, Aff2, Aff11
Winter, Jill
Walzl, GerhardAff1, Aff2
Warwick, James M.
the Catalysis Biomarker Consortium
Pokaż więcej
Źródło:
EJNMMI Research. 8(1)
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 61

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies